Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for the Treatment of Major Depression in Youth With Bipolar Disorder
NCT00005015Phase 3Terminated
- Sponsor
- National Institute of Mental Health
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fluoxetine in bipolar disorder (BD), major depressive disorder (MDD), sponsored by National Institute of Mental Health. Status: terminated.
02
Drugs
fluoxetine
03
Conditions
bipolar disorder (BD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00005015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005015.